Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Licence: CC BY 4.0
ID Serval
serval:BIB_017CC4FF5C4F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.
Périodique
European journal of cancer
Auteur⸱e⸱s
Ceppi F., Gotti G., Möricke A., Silvestri D., Poyer F., Lentes J., Bergmann A., Trka J., Alten J., Elitzur S., Barbaric D., Buldini B., Dell'Acqua F., Schumacher F., Casazza G., Tchinda J., Nebral K., Conter V., Attarbaschi A., Schrappe M.
ISSN
1879-0852 (Electronic)
ISSN-L
0959-8049
Statut éditorial
Publié
Date de publication
11/2022
Peer-reviewed
Oui
Volume
175
Pages
120-124
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Near-tetraploidy-defined by DNA index 1.79-2.28 or 81-103 chromosomes-is a rare cytogenetic abnormality observed both in children and adults with T-cell acute lymphoblastic leukaemia (T-ALL) and its prognostic value is not yet determined.
We report a retrospective study conducted in paediatric patients with newly diagnosed T-ALL treated in AIEOP-BFM ALL 2000 and 2009 studies. 31 near-tetraploid T-ALL patients (1.4%) are compared to T-ALL patients without near-tetraploidy.
Near-tetraploid karyotype was associated with lower frequency of high-risk features: white blood cells count at diagnosis ≥100,000/μL (19.3% versus 41.0%, p-value < 0.001), PPR (13.3% versus 35.8%, p-value = 0.01) and minimal residual disease high-risk at the end of consolidation phase Induction B (4.03% versus 14.6%, p-value = 0.001). Complete remission was achieved at the end of induction phase (day 33) in 100% near-tetraploid T-ALL patients, compared to 93.2% T-ALL without near-tetraploidy.
Overall, we found that near-tetraploid T-ALL in newly diagnosed paediatric patients is associated with low-risk presenting features, with favourable treatment response and outcome.
Mots-clé
Adult, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Child, DNA, Humans, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics, Prognosis, Retrospective Studies, T-Lymphocytes, Tetraploidy, Treatment Outcome, Children, Genetic, T-cell acute lymphoblastic leukaemia
Pubmed
Web of science
Open Access
Oui
Création de la notice
27/09/2022 13:20
Dernière modification de la notice
15/08/2023 7:00
Données d'usage